In a major step toward self-sufficiency in advanced cancer care, scientists at a premier Chinese research facility say they have the capability to produce medical isotopes known as "nuclear warheads" for their ability to destroy tumors with pinpoint accuracy. The breakthrough at the China Spallation Neutron Source in Dongguan, Guangdong province, targets a critical bottleneck in the country's healthcare system: a long-standing reliance on expensive, unstable imports of alpha isotopes.

The 15th International Conference on Polarized Neutrons in Condensed Matter Investigations (PNCMI 2025), held from February 24 to 28, 2025, in Dongguan, Guangdong, brought together leading experts to discuss the latest advancements in polarized neutron platforms and their applications in condensed matter research, as well as future developments in the field. The event attracted over 70 experts from more than 20 research institutions and universities worldwide.

On January 10–11, the CSNS hosted the Second Muon Application Workshop for the Muon Source Station.